It gives Novo Nordisk an opportunity to remain competitive on efficacy while it continues developing next-generation therapies. Other drugs have already shown greater efficacy in prior studies, and the broader GLP-1 space is likely to see much more significant change as new molecules enter the market. Balazs called the higher dosage a major jump, noting that the incidences of stomach- and skin-related side effects at this higher dose are meaningful. CLICK HERE FOR MORE HEALTH STORIES This approval is for obesity management, not diabetes treatment, the expert emphasized
An agent will facilitate communication with your insurance company, to ensure you're getting as much covered as possible
Explored BPC-157's role in the brain-gut axis and neuroprotective mechanisms
This article does not determine clinical suitability for any individual reader
To avoid the degradation, we applied the serum-free medium which didn't contain dipeptidyl peptidase (DPP)-4
Indeed, each generic entrant can slash brand prices by roughly 40% or more ( [14] ), dramatically expanding patient access
